Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Treatment with Mannitol is Associated with Increased Risk for In-Hospital Mortality in Patients with Acute Ischemic Stroke and Cerebral Edema

Treatment with Mannitol is Associated with Increased Risk for In-Hospital Mortality in Patients... Am J Cardiovasc Drugs (2018) 18:397–403 https://doi.org/10.1007/s40256-018-0285-0 ORIGINAL RESEARCH ARTICLE Treatment with Mannitol is Associated with Increased Risk for In-Hospital Mortality in Patients with Acute Ischemic Stroke and Cerebral Edema 1 1 1 • • • Marianthi Papagianni Konstantinos Tziomalos Stavroula Kostaki 1 1 1 • • • Stella-Maria Angelopoulou Konstantinos Christou Stella D. Bouziana 1 1 1 • • • Maria Vergou Triantafyllos Didangelos Christos Savopoulos Apostolos I. Hatzitolios Published online: 30 May 2018 Springer International Publishing AG, part of Springer Nature 2018 Abstract Conclusions Administration of mannitol to patients with Background Current guidelines state that osmotic therapy ischemic stroke-related cerebral edema does not appear to is reasonable in patients with clinical deterioration from affect the functional outcome and might increase mortality, cerebral infarction-related cerebral edema. However, there independently of stroke severity. are limited data on the safety and efficacy of this therapy. We aimed to evaluate the effect of mannitol on the out- come of ischemic stroke-related cerebral edema. Key Points Methods and Results We prospectively studied 922 con- secutive patients admitted with acute ischemic stroke. In patients with cerebral edema due to acute Patients who showed space-occupying brain edema with ischemic stroke, mannitol does not appear http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png American Journal of Cardiovascular Drugs Springer Journals

Treatment with Mannitol is Associated with Increased Risk for In-Hospital Mortality in Patients with Acute Ischemic Stroke and Cerebral Edema

Download PDF
7 pages
Read Article

Loading next page...
 
/lp/springer_journal/treatment-with-mannitol-is-associated-with-increased-risk-for-in-PzQbOkVFv4
Publisher
Springer Journals
Copyright
Copyright © 2018 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Cardiology; Pharmacotherapy; Pharmacology/Toxicology
ISSN
1175-3277
eISSN
1179-187X
DOI
10.1007/s40256-018-0285-0
Publisher site
See Article on Publisher Site

Abstract

Am J Cardiovasc Drugs (2018) 18:397–403 https://doi.org/10.1007/s40256-018-0285-0 ORIGINAL RESEARCH ARTICLE Treatment with Mannitol is Associated with Increased Risk for In-Hospital Mortality in Patients with Acute Ischemic Stroke and Cerebral Edema 1 1 1 • • • Marianthi Papagianni Konstantinos Tziomalos Stavroula Kostaki 1 1 1 • • • Stella-Maria Angelopoulou Konstantinos Christou Stella D. Bouziana 1 1 1 • • • Maria Vergou Triantafyllos Didangelos Christos Savopoulos Apostolos I. Hatzitolios Published online: 30 May 2018 Springer International Publishing AG, part of Springer Nature 2018 Abstract Conclusions Administration of mannitol to patients with Background Current guidelines state that osmotic therapy ischemic stroke-related cerebral edema does not appear to is reasonable in patients with clinical deterioration from affect the functional outcome and might increase mortality, cerebral infarction-related cerebral edema. However, there independently of stroke severity. are limited data on the safety and efficacy of this therapy. We aimed to evaluate the effect of mannitol on the out- come of ischemic stroke-related cerebral edema. Key Points Methods and Results We prospectively studied 922 con- secutive patients admitted with acute ischemic stroke. In patients with cerebral edema due to acute Patients who showed space-occupying brain edema with ischemic stroke, mannitol does not appear

Journal

American Journal of Cardiovascular Drugs – Springer Journals

Published: May 30, 2018

References

  • Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015
  • Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010
    Murray, CJ; Vos, T; Lozano, R; Naghavi, M; Flaxman, AD; Michaud, C; Ezzati, M; Shibuya, K; Salomon, JA; Abdalla, S; Aboyans, V; Abraham, J; Ackerman, I; Aggarwal, R; Ahn, SY; Ali, MK; Alvarado, M; Anderson, HR; Anderson, LM; Andrews, KG; Atkinson, C; Baddour, LM; Bahalim, AN; Barker-Collo, S; Barrero, LH; Bartels, DH; Basáñez, MG; Baxter, A; Bell, ML; Benjamin, EJ; Bennett, D; Bernabé, E; Bhalla, K; Bhandari, B; Bikbov, B; Bin Abdulhak, A; Birbeck, G; Black, JA; Blencowe, H; Blore, JD; Blyth, F; Bolliger, I; Bonaventure, A; Boufous, S; Bourne, R; Boussinesq, M; Braithwaite, T; Brayne, C; Bridgett, L; Brooker, S; Brooks, P; Brugha, TS; Bryan-Hancock, C; Bucello, C; Buchbinder, R; Buckle, G; Budke, CM; Burch, M; Burney, P; Burstein, R; Calabria, B; Campbell, B; Canter, CE; Carabin, H; Carapetis, J; Carmona, L; Cella, C; Charlson, F; Chen, H; Cheng, AT; Chou, D; Chugh, SS; Coffeng, LE; Colan, SD; Colquhoun, S; Colson, KE; Condon, J; Connor, MD; Cooper, LT; Corriere, M; Cortinovis, M; Vaccaro, KC; Couser, W; Cowie, BC; Criqui, MH; Cross, M; Dabhadkar, KC; Dahiya, M; Dahodwala, N; Damsere-Derry, J; Danaei, G; Davis, A; Leo, D; Degenhardt, L; Dellavalle, R; Delossantos, A; Denenberg, J; Derrett, S; Des Jarlais, DC; Dharmaratne, SD; Dherani, M; Diaz-Torne, C; Dolk, H; Dorsey, ER; Driscoll, T; Duber, H; Ebel, B; Edmond, K; Elbaz, A; Ali, SE; Erskine, H; Erwin, PJ; Espindola, P; Ewoigbokhan, SE; Farzadfar, F; Feigin, V; Felson, DT; Ferrari, A; Ferri, CP; Fèvre, EM; Finucane, MM; Flaxman, S; Flood, L; Foreman, K; Forouzanfar, MH; Fowkes, FG; Fransen, M; Freeman, MK; Gabbe, BJ; Gabriel, SE; Gakidou, E; Ganatra, HA; Garcia, B; Gaspari, F; Gillum, RF; Gmel, G; Gonzalez-Medina, D; Gosselin, R; Grainger, R; Grant, B; Groeger, J; Guillemin, F; Gunnell, D; Gupta, R; Haagsma, J; Hagan, H; Halasa, YA; Hall, W; Haring, D; Haro, JM; Harrison, JE; Havmoeller, R; Hay, RJ; Higashi, H; Hill, C; Hoen, B; Hoffman, H; Hotez, PJ; Hoy, D; Huang, JJ; Ibeanusi, SE; Jacobsen, KH; James, SL; Jarvis, D; Jasrasaria, R; Jayaraman, S; Johns, N; Jonas, JB; Karthikeyan, G; Kassebaum, N; Kawakami, N; Keren, A; Khoo, JP; King, CH; Knowlton, LM; Kobusingye, O; Koranteng, A; Krishnamurthi, R; Laden, F; Lalloo, R; Laslett, LL; Lathlean, T; Leasher, JL; Lee, YY; Leigh, J; Levinson, D; Lim, SS; Limb, E; Lin, JK; Lipnick, M; Lipshultz, SE; Liu, W; Loane, M; Ohno, SL; Lyons, R; Mabweijano, J; MacIntyre, MF; Malekzadeh, R; Mallinger, L; Manivannan, S; Marcenes, W; March, L; Margolis, DJ; Marks, GB; Marks, R; Matsumori, A; Matzopoulos, R; Mayosi, BM; McAnulty, JH; McDermott, MM; McGill, N; McGrath, J; Medina-Mora, ME; Meltzer, M; Mensah, GA; Merriman, TR; Meyer, AC; Miglioli, V; Miller, M; Miller, TR; Mitchell, PB; Mock, C; Mocumbi, AO; Moffitt, TE; Mokdad, AA; Monasta, L; Montico, M; Moradi-Lakeh, M; Moran, A; Morawska, L; Mori, R; Murdoch, ME; Mwaniki, MK; Naidoo, K; Nair, MN; Naldi, L; Narayan, KM; Nelson, PK; Nelson, RG; Nevitt, MC; Newton, CR; Nolte, S; Norman, P; Norman, R; O’Donnell, M; O’Hanlon, S; Olives, C; Omer, SB; Ortblad, K; Osborne, R; Ozgediz, D; Page, A; Pahari, B; Pandian, JD; Rivero, AP; Patten, SB; Pearce, N; Padilla, RP; Perez-Ruiz, F; Perico, N; Pesudovs, K; Phillips, D; Phillips, MR; Pierce, K; Pion, S; Polanczyk, GV; Polinder, S; Pope, CA; Popova, S; Porrini, E; Pourmalek, F; Prince, M; Pullan, RL; Ramaiah, KD; Ranganathan, D; Razavi, H; Regan, M; Rehm, JT; Rein, DB; Remuzzi, G; Richardson, K; Rivara, FP; Roberts, T; Robinson, C; Leòn, FR; Ronfani, L; Room, R; Rosenfeld, LC; Rushton, L; Sacco, RL; Saha, S; Sampson, U; Sanchez-Riera, L; Sanman, E; Schwebel, DC; Scott, JG; Segui-Gomez, M; Shahraz, S; Shepard, DS; Shin, H; Shivakoti, R; Singh, D; Singh, GM; Singh, JA; Singleton, J; Sleet, DA; Sliwa, K; Smith, E; Smith, JL; Stapelberg, NJ; Steer, A; Steiner, T; Stolk, WA; Stovner, LJ; Sudfeld, C; Syed, S; Tamburlini, G; Tavakkoli, M; Taylor, HR; Taylor, JA; Taylor, WJ; Thomas, B; Thomson, WM; Thurston, GD; Tleyjeh, IM; Tonelli, M; Towbin, JA; Truelsen, T; Tsilimbaris, MK; Ubeda, C; Undurraga, EA; Werf, MJ; Os, J; Vavilala, MS; Venketasubramanian, N; Wang, M; Wang, W; Watt, K; Weatherall, DJ; Weinstock, MA; Weintraub, R; Weisskopf, MG; Weissman, MM; White, RA; Whiteford, H; Wiebe, N; Wiersma, ST; Wilkinson, JD; Williams, HC; Williams, SR; Witt, E; Wolfe, F; Woolf, AD; Wulf, S; Yeh, PH; Zaidi, AK; Zheng, ZJ; Zonies, D; Lopez, AD; AlMazroa, MA; Memish, ZA
  • Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010
    Feigin, VL; Forouzanfar, MH; Krishnamurthi, R; Mensah, GA; Connor, M; Bennett, DA; Moran, AE; Sacco, RL; Anderson, L; Truelsen, T; O’Donnell, M; Venketasubramanian, N; Barker-Collo, S; Lawes, CM; Wang, W; Shinohara, Y; Witt, E; Ezzati, M; Naghavi, M; Murray, C
  • Brain edema after ischaemic stroke
    Dostovic, Z; Dostovic, E; Smajlovic, D; Ibrahimagic, OC; Avdic, L
  • Brain edema predicts outcome after nonlacunar ischemic stroke
    Battey, TW; Karki, M; Singhal, AB; Wu, O; Sadaghiani, S; Campbell, BC; Davis, SM; Donnan, GA; Sheth, KN; Kimberly, WT
  • Predictors of fatal brain edema in massive hemispheric ischemic stroke
    Kasner, SE; Demchuk, AM; Berrouschot, J; Schmutzhard, E; Harms, L; Verro, P; Chalela, JA; Abbur, R; McGrade, H; Christou, I; Krieger, DW
  • ‘Malignant’ middle cerebral artery territory infarction: clinical course and prognostic signs
    Hacke, W; Schwab, S; Horn, M; Spranger, M; Georgia, M; Kummer, R
  • Timing of neurologic deterioration in massive middle cerebral artery infarction: a multicenter review
    Qureshi, AI; Suarez, JI; Yahia, AM; Mohammad, Y; Uzun, G; Suri, MF; Zaidat, OO; Ayata, C; Ali, Z; Wityk, RJ
  • Hacke W; DESTINY II Investigators. Hemicraniectomy in older patients with extensive middle-cerebral-artery stroke
    Jüttler, E; Unterberg, A; Woitzik, J; Bösel, J; Amiri, H; Sakowitz, OW; Gondan, M; Schiller, P; Limprecht, R; Luntz, S; Schneider, H; Pinzer, T; Hobohm, C; Meixensberger, J
  • Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials
    Vahedi, K; Hofmeijer, J; Juettler, E; Vicaut, E; George, B; Algra, A; Amelink, GJ; Schmiedeck, P; Schwab, S; Rothwell, PM; Bousser, MG; van der Worp, HB; Hacke, W
  • Antiedema therapy in ischemic stroke
    Bardutzky, J; Schwab, S
  • Recommendations for the management of cerebral and cerebellar infarction with swelling: a statement for healthcare professionals from the American Heart Association/American Stroke Association
    Wijdicks, EF; Sheth, KN; Carter, BS; Greer, DM; Kasner, SE; Kimberly, WT; Schwab, S; Smith, EE; Tamargo, RJ; Wintermark, M
  • Effects of body position on intracranial pressure and cerebral perfusion in patients with large hemispheric stroke
    Schwarz, S; Georgiadis, D; Aschoff, A; Schwab, S
  • Cerebral apoplexy (stroke) treated with or without prolonged artificial hyperventilation. 1. Cerebral circulation, clinical course, and cause of death
    Christensen, MS; Paulson, OB; Olesen, J; Alexander, SC; Skinhoj, E; Dam, WH; Lassen, NA
  • Corticosteroids for acute ischaemic stroke
    Sandercock, PA; Soane, T
  • Effects of hypertonic (10%) saline in patients with raised intracranial pressure after stroke
    Schwarz, S; Georgiadis, D; Aschoff, A; Schwab, S
  • Cerebral hemodynamic and metabolic effects of equi-osmolar doses mannitol and 23.4% saline in patients with edema following large ischemic stroke
    Diringer, MN; Scalfani, MT; Zazulia, AR; Videen, TO; Dhar, R
  • The role of osmotic therapy in hemispheric stroke
    Ong, CJ; Keyrouz, SG; Diringer, MN
  • Reversal of transtentorial herniation with hypertonic saline
    Koenig, MA; Bryan, M; Lewin, JL; Mirski, MA; Geocadin, RG; Stevens, RD
  • Therapy against brain swelling in stroke patients. A retrospective clinical study on 227 patients
    Candelise, L; Colombo, A; Spinnler, H
  • Is there a real treatment for stroke? Clinical and statistical comparison of different treatments in 300 patients
    Santambrogio, S; Martinotti, R; Sardella, F; Porro, F; Randazzo, A
  • Mannitol use in acute stroke: case fatality at 30 days and 1 year
    Bereczki, D; Mihálka, L; Szatmári, S; Fekete, K; Cesar, D; Fülesdi, B; Csiba, L; Fekete, I
  • Mannitol for acute stroke
    Bereczki, D; Fekete, I; Prado, GF; Liu, M
  • Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
    Friedewald, WT; Levy, RI; Fredrickson, DS
  • A new equation to estimate glomerular filtration rate
    Levey, AS; Stevens, LA; Schmid, CH; Zhang, YL; Castro, AF; Feldman, HI; Kusek, JW; Eggers, P; Van, Lente F; Greene, T; Coresh, J
  • Molecular pathophysiology of cerebral edema
    Stokum, JA; Gerzanich, V; Simard, JM
  • Multimodal online monitoring in middle cerebral artery territory stroke
    Steiner, T; Pilz, J; Schellinger, P; Wirtz, R; Friederichs, V; Aschoff, A; Hacke, W
  • Effects of hypertonic saline hydroxyethyl starch solution and mannitol in patients with increased intracranial pressure after stroke
    Schwarz, S; Schwab, S; Bertram, M; Aschoff, A; Hacke, W
  • Osmotic therapy: fact and fiction
    Diringer, MN; Zazulia, AR
  • Mannitol bolus preferentially shrinks non-infarcted brain in patients with ischemic stroke
    Videen, TO; Zazulia, AR; Manno, EM; Derdeyn, CP; Adams, RE; Diringer, MN; Powers, WJ
  • The effects of mannitol on cerebral edema after large hemispheric cerebral infarct
    Manno, EM; Adams, RE; Derdeyn, CP; Powers, WJ; Diringer, MN
  • Cerebral perfusion pressure: a hemodynamic mechanism of mannitol and the postmannitol hemogram
    Rosner, MJ; Coley, I
  • The puzzle of neuronal death and life: is mannitol the right drug for the treatment of brain oedema associated with ischaemic stroke?
    Famularo, G